Award
NIH Reporter #4R01CA292654-03
A translational study of a synthetic lethality interaction of CD105 and androgen receptor signaling axis for castration-resistant prostate cancer patients
Recipient
Cedars-Sinai Medical Center
Award Amount
$1,813,962.00
Ceiling
$1,813,962.00
Awarded
August 11, 2026
Identifier
4R01CA292654-03
This award supports a translational research project investigating the interaction between CD105 and androgen receptor signaling in castration-resistant prostate cancer, aiming to develop new therapeutic strategies.
Description
The project involves a translational study on prostate cancer focusing on androgen receptor signaling and resistance mechanisms. The project aims to develop novel therapeutic strategies and understand molecular mechanisms. It involves clinical trials, molecular analysis, and nanotechnology platforms.